Journal Article Porphyrin Derivatives-Mediated Sonodynamic Therapy for Malignant Gliomas In Vitro

Endo, Shogo  ,  Kudo, Nobuki  ,  Yamaguchi, Shigeru  ,  Sumiyoshi, Koki  ,  Motegi, Hiroaki  ,  Kobayashi, Hiroyuki  ,  Terasaka, Shunsuke  ,  Houkin, Kiyohiro

41 ( 9 )  , pp.2458 - 2465 , 2015-09 , Elsevier
Because it is highly infiltrative, malignant glioma is a cancer with a poor prognosis despite multidisciplinary treatment strategies, such as aggressive surgery and chemoradiotherapy, necessitating new therapeutic approaches to control migration of tumor cells. In our study, we investigated the efficacy of sonodynamic therapy of glioma cells in vitro using porphyrin derivatives, including 5-aminolevulinic acid, protoporphyrin IX and talaporfin sodium, as sonosensitizers. These substances have been known to accumulate in glioma cells and are expected to have cytotoxic effects on sonication. Our study found that the cytotoxicity of sonication of glioma cells is enhanced by each sonosensitizer and that the efficacy of sonodynamic therapy may depend on the degree of intracellular accumulation of sonosensitizer. Also, the study suggests that induction of apoptosis is a major mechanism underlying cell death. Though further investigations are necessary, our preliminary result indicates a potential for sonodynamic therapy with sonosensitizers in glioma treatment.

Number of accesses :  

Other information